China's Sichuan Kelun-Biotech Biopharmaceutical (6990.HK) said Thursday night it would license an experimental cancer ...
Lagging behind the PD-1xVEGF leaders, Crescent has strengthened its hand by licensing Kelun’s integrin beta-6 ...
Partnership with Kelun-Biotech expands pipeline and accelerates combination strategy with CR-001, a PD-1 x VEGF bispecific ...
The partnership will focus on Crescent’s PD-1/VEGF inhibitor CR-001 and Kelun-Biotech’s SKB105, both of which the companies ...
Pharmaceutical Technology on MSN
Crescent and Kelun-Biotech swap cancer asset rights in double deal
"Crescent and Kelun-Biotech swap cancer asset rights in double deal " was originally created and published by Pharmaceutical ...
Our pumpkin filled dessert crescent rolls recipe transforms classic pumpkin pie into something handheld, ...
Crescent Energy said it agreed to sell its non-operated DJ Basin assets to an unnamed private buyer for $90 million in cash, ...
Crescent Communities and Heitman are expanding their presence in the build-to-rent sector with the formation of a second ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback